You Cannot Govern What You Cannot See — And Why Visibility Matters More Than Ever in Distributed Laboratory Networks

Whether you run a health system laboratory network or an independent laboratory operating across multiple locations, your testing footprint has never been more distributed. According to CMS CLIA data, there are now more than 317,000 CLIA-certified laboratories in the U.S., and roughly 80% of them — approximately 245,000 — hold Certificates of Waiver (CMS CLIA Registry, March 2024). That means the vast majority of testing sites in your network are not high-complexity laboratories with dedicated quality teams. They are clinics, POCT sites, draw stations, client service locations, and satellite facilities.  And many of them operate with limited centralized visibility.

This article is for laboratory leaders who feel confident about their core operations, but may not yet have full visibility into what is happening across the rest of their testing network. Because in a distributed environment, what you cannot see becomes more than a blind spot — it becomes unmanaged risk.

The Confidence Gap in Multi-Site Laboratory Operations

Most laboratory directors, whether they lead a health system network or an independent laboratory with multiple locations, believe their operations are well-managed. Their core laboratories run smoothly. Their teams know what they are doing. Their processes are documented and followed.

And in many cases, that is true, but only for the sites they can see.

But here is the challenge. A 2023 systematic review in the International Journal for Quality in Health Care found that incident reporting systems capture a median of just 3.9% of adverse events — meaning more than 96% go undetected through standard reporting channels (Hibbert et al., 2023). If that detection gap exists at the enterprise level, consider how much wider it becomes when disconnected sites are expected to self-report quality events.

The confidence leaders feel is often grounded in the data available to them, but may not fully reflect what is happening in less visible parts of the network.

How Did Testing Become So Distributed?

The global point-of-care testing market reached $44.5 billion in 2025 and is projected to reach $125 billion by 2034, growing at a 12.2% CAGR (Precedence Research, 2025). That growth is not abstract — it shows up in every organizational chart. Testing now happens across hospital laboratories, POCT and waived testing sites, physician practice management locations, clinics, specialty practices, freestanding EDs, patient service centers, and draw stations.

At the same time, consolidation keeps accelerating across the industry. According to the most recent AHA Fast Facts on U.S. Hospitals (2026 edition, reflecting 2024 survey data), 3,567 community hospitals — roughly 70% — are now part of a health system, with more than 400 health systems operating nationwide. Kaufman Hall recorded 72 hospital M&A transactions in 2024 — the most since 2020 — and in 2025, a record 43.5% of announced transactions involved a financially distressed organization (Kaufman Hall, January 2026). Independent reference laboratories face the same dynamic: as they grow through new client sites, mobile draw locations, and regional expansion, their testing footprint outpaces the systems they built to manage it.

The result is that most multi-site laboratory organizations, health systems and independent laboratories alike, now have a testing footprint that wasn’t necessarily designed to be managed as a single network. Sites use different tools, follow different workflows, and report differently—or not at all. That creates a condition that is difficult to detect and dangerous to ignore: variation without visibility.

What Happens When There Is No True Standardization?

This is not theoretical. It shows up in very real ways — often in ways that are difficult to address once they surface.

1. Survey Readiness Becomes Difficult to Maintain Across All Sites

Quality oversight may be strong at your primary laboratory locations. But survey activity does not stop at the core laboratory. Surveyors follow the specimen, the workflow, and the staff — and that path increasingly leads into clinics, POCT environments, and satellite testing locations.

CMS data shows that proficiency testing (D2016) and personnel requirements for moderate-complexity laboratories (D6000) were the top two CLIA deficiencies in 2024, cited in 738 and 709 laboratories, respectively. Competency assessment has been among the most commonly cited deficiencies across CAP, Joint Commission, and COLA for decades. When satellite sites are not operating within the same quality framework, these findings do not just appear — they repeat across locations. Gaps surface that leadership did not know existed, and confidence erodes both internally and externally.

"Gaps often surface during inspection rather than through internal visibility."

2. System-Level Visibility Breaks Down

When sites operate on different applications, data fragments are created. Reporting becomes inconsistent. Trends become impossible to identify. It becomes difficult to identify risk early, enforce consistency, or answer simple system-level questions, such as: How many open testing-related corrective actions exist across all sites right now?

Eventually, local teams are managing what is fundamentally system-level risk.  That creates a gap between local management and system-level oversight.

3. Quality Events Happen — But They Do Not Surface

In a piecemeal model, some sites report events, some do not, and some track them locally in spreadsheets that never surface to leadership. The systematic review referenced earlier found that, across 12 of 14 studies, fewer than 10% of adverse events detected by chart review were reported in incident reporting systems (Hibbert et al., International Journal for Quality in Health Care, 2023). That is a tenfold detection gap.

For laboratory leaders, this means underreported issues, missed trends, and delayed responses to systemic problems. It is one of the most common gaps in multi-site operations — and one of the most important to address.

4. Skilled Staff Spend Their Time Compensating for Fragmented Systems

Instead of driving quality improvement, advancing programs, and leading strategically, the most capable staff are chasing documentation, reconciling inconsistencies, and managing manual workarounds. Research shows that pre-analytical errors account for 60–70% of all laboratory errors—the kind that multiply when processes are not standardized across sites.  Highly skilled staff often spend time compensating for fragmented systems rather than focusing on higher-value quality improvement work. That is expensive, unsustainable, and it drives attrition among the people they can least afford to lose.

A peer-reviewed survey of 2,363 pathology and laboratory professionals found that 58.4% reported burnout, with quality maintenance and compliance work cited as the most burdensome and least valued type of work (Archives of Pathology & Laboratory Medicine, 2022). When systems are fragmented, compliance work does not just take longer — it becomes the responsibility that drives good people out.

5. Growth Compounds the Problem

Every new site adds new variation, new workflows, and new risk — whether it is a health system acquiring another hospital or an independent laboratory expanding into new service areas. With 72 hospital M&A transactions in 2024 and a record 43.5% involving financially distressed organizations in 2025 (Kaufman Hall), health systems are absorbing sites already struggling with quality management. Independent laboratories face a parallel challenge: each new client site, draw station, or regional location stretches existing oversight further. Without a standardized approach, complexity compounds faster than any team can manage it.

Why Does This Problem Persist?  Because the Current State Often Feels Manageable.

That is the most difficult part. Surveys still result in favorable outcomes — until they do not. Teams are managing day to day. Issues get handled locally. From the top, the operation appears sound.

But risk may still be accumulating in areas that are difficult to see consistently. And the December 2023 CLIA Final Rule (CMS-3326-F), effective January 27, 2024, raised the stakes: CMS expanded enforcement sanctions for Certificate of Waiver laboratories for the first time. Waived-testing sites now face civil monetary penalties of $50–$3,000 per day for condition-level deficiencies that do not pose immediate jeopardy, and up to $10,000 per day at the statutory baseline for immediate jeopardy conditions (CMS, 42 CFR 493.1834). Previously, the principal sanctions available were suspension, limitation, or revocation of the CLIA certificate. Now there is real financial exposure — at the sites that are least likely to have quality oversight in place.

Why Piecemeal Models Break Down — Even When They Seem Logical

Many organizations try to "right-size" by giving different sites different tools. The core laboratory gets the full QMS. Clinics get a simplified version. POCT sites get spreadsheets or nothing. It feels practical.

But it creates disconnected data, inconsistent workflows, and broken visibility. And ultimately, it creates an environment that is difficult to govern consistently. Organizations can manage sites individually. They can rely on local compliance. They can react to issues as they surface. But they cannot see across the network, identify risk early, or enforce consistency. That is the difference between managing and governing.

POCT error rates illustrate why this matters. A peer-reviewed study using standardized quality indicators found a 45.3% error rate for patient identification failures at POCT sites, compared to 0.02% in the central laboratory — errors tied specifically to failure to confirm two patient identifiers at the point of care (Llopis et al., Clinical Chemistry and Laboratory Medicine, 2012). These are not sites any organization can afford to leave outside its quality system.

What Are Leading Organizations Doing Differently?

The organizations that are ahead have made a critical shift: they standardize the platform, not just the process. They ensure every site — from the core laboratory to the smallest draw station — operates within the same quality management system. Every workflow connects. Every data point contributes to system-level visibility.

Not because every site needs the same complexity. But because every site contributes to the same risk profile.

The laboratory software market reflects this shift. It is projected to grow from $6.3 billion in 2025 to $10.1 billion by 2030 (MarketsandMarkets, 2025) — driven largely by the need for real-time data visibility and compliance infrastructure that scales across distributed networks.

In practice, this does not require forcing every site into the same level of complexity. Leading organizations focus on three practical steps:

• Establish a shared system of record for testing-related quality activities across all sites
• Standardize core workflows such as competency, incident tracking, and inspection readiness
• Create lab system-level reporting that allows leadership to see risk, trends, and gaps in real time

The goal is not uniformity for its own sake — it is visibility, consistency, and the ability to act early.

The Leadership Shift This Moment Requires

This is where laboratory leaders have an opportunity to step forward. Not just as managers of the core laboratory, but as owners of quality across the entire testing network.

That requires asking direct questions:

• Where do we lack visibility today?
• Which sites and processes are operating outside our quality system?
• Are we genuinely confident in testing-related consistency across all locations?
• Can we actually see our risk — or are we assuming it is managed?
• Are quality events surfacing in real time, or only after they have already compounded?

With the December 2023 CLIA Final Rule now in effect, the number of CLIA-certified locations growing past 317,000, and both health system M&A and independent laboratory expansion showing no signs of slowing, the window for getting ahead of this is narrowing.

The Bottom Line

Whether you are a health system or an independent laboratory, the reality is the same: testing and risk are distributed. But accountability is not.

Without visibility, it becomes difficult to manage and control the system effectively. And if you cannot control it, you are carrying a risk you do not fully understand.

The laboratories that recognize this now — and invest in platform-level visibility across every testing site — will not just be more compliant. They will operate with greater confidence, scale more effectively, and be fundamentally better positioned to lead.

Explore how organizations are approaching standardization and gaining visibility across their testing networks. -> Read our Case Studies

‍

‍

‍